[29] Mutations in chromatin modifier genes, including ARID1B, and ARID2, were also common, a finding in line with prior studies of PTCL occurring in immunocompetent hosts. The gene discussed is ARID2; the disease is mature T-cell and NK-cell non-Hodgkin lymphoma.